• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery.采用 96 孔板真空干燥系统评价无定形固体分散体药物传递中的载药量和聚合物。
AAPS PharmSciTech. 2012 Jun;13(2):713-22. doi: 10.1208/s12249-012-9795-2. Epub 2012 May 5.
2
Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.无定形三元固体分散体的无定形稳定化与溶出度增强:具有药物 - 聚合物相互作用以产生协同效应的聚合物组合
J Pharm Sci. 2014 Nov;103(11):3511-3523. doi: 10.1002/jps.24137. Epub 2014 Sep 5.
3
Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?无定形药物的溶解度优势,第3部分:最大溶解度优势在实验上是否可实现且可持续?
J Pharm Sci. 2011 Oct;100(10):4349-56. doi: 10.1002/jps.22643. Epub 2011 May 31.
4
Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.在制备和储存过程中白藜芦醇无定形固体分散体的结晶-不同聚合物的影响。
J Pharm Sci. 2013 Jan;102(1):171-84. doi: 10.1002/jps.23358. Epub 2012 Nov 6.
5
Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.喷雾干燥三元无定形固体分散体的固态特性和溶出特性研究:多组分无定形系统设计和开发的合理步骤。
Mol Pharm. 2018 Sep 4;15(9):3796-3812. doi: 10.1021/acs.molpharmaceut.8b00306. Epub 2018 Jul 30.
6
Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.由聚丙烯酸和纤维素衍生物配制的高载药量非晶态固体分散体中塞来昔布的释放改善
Mol Pharm. 2016 Mar 7;13(3):873-84. doi: 10.1021/acs.molpharmaceut.5b00798. Epub 2016 Feb 2.
7
Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.采用聚合物组合制备的高载药量塞来昔布无定形固体分散体的溶出性能
Pharm Res. 2016 Mar;33(3):739-50. doi: 10.1007/s11095-015-1823-y. Epub 2015 Nov 12.
8
Comparison of two DSC-based methods to predict drug-polymer solubility.两种基于 DSC 的方法预测药物-聚合物溶解度的比较。
Int J Pharm. 2018 Apr 5;540(1-2):98-105. doi: 10.1016/j.ijpharm.2018.02.002. Epub 2018 Feb 6.
9
Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.使用羟丙甲纤维素邻苯二甲酸酯/羟丙基纤维素固体分散体混合物进行特定部位的溶解度改善。
Eur J Pharm Biopharm. 2014 Jul;87(2):264-70. doi: 10.1016/j.ejpb.2014.03.018. Epub 2014 Apr 21.
10
and Behaviors of KinetiSol and Spray-Dried Amorphous Solid Dispersions of a Weakly Basic Drug and Ionic Polymer†.动力学溶液和喷雾干燥无定形固体分散体的弱碱性药物和离子聚合物的行为†。
Mol Pharm. 2020 Aug 3;17(8):2789-2808. doi: 10.1021/acs.molpharmaceut.0c00108. Epub 2020 Jul 6.

引用本文的文献

1
Optimization of Spray-Drying Parameters for Formulation Development at Preclinical Scale.优化喷雾干燥参数,以开发临床前规模的配方。
AAPS PharmSciTech. 2021 Dec 20;23(1):28. doi: 10.1208/s12249-021-02160-1.
2
Automation and data-driven design of polymer therapeutics.聚合物治疗药物的自动化和数据驱动设计。
Adv Drug Deliv Rev. 2021 Apr;171:1-28. doi: 10.1016/j.addr.2020.11.009. Epub 2020 Nov 24.
3
Vacuum Compression Molding as a Screening Tool to Investigate Carrier Suitability for Hot-Melt Extrusion Formulations.真空压缩成型作为一种筛选工具,用于研究载体对热熔挤出制剂的适用性。
Pharmaceutics. 2020 Oct 24;12(11):1019. doi: 10.3390/pharmaceutics12111019.
4
A Novel Rheological Method to Assess Drug-Polymer Interactions Regarding Miscibility and Crystallization of Drug in Amorphous Solid Dispersions for Oral Drug Delivery.一种用于评估口服给药无定形固体分散体中药物与聚合物相互作用(涉及药物的混溶性和结晶)的新型流变学方法。
Pharmaceutics. 2019 Nov 22;11(12):625. doi: 10.3390/pharmaceutics11120625.
5
High-Throughput Dissolution/Permeation Screening -A 96-Well Two-Compartment Microplate Approach.高通量溶出/渗透筛选——一种96孔双室微孔板方法。
Pharmaceutics. 2019 May 10;11(5):227. doi: 10.3390/pharmaceutics11050227.
6
A Novel Protocol Using Small-Scale Spray-Drying for the Efficient Screening of Solid Dispersions in Early Drug Development and Formulation, as a Straight Pathway from Screening to Manufacturing Stages.一种用于早期药物研发和制剂中固体分散体高效筛选的新型小规模喷雾干燥方案,作为从筛选到生产阶段的直接途径。
Pharmaceuticals (Basel). 2018 Aug 27;11(3):81. doi: 10.3390/ph11030081.
7
Prediction of Phase Behavior of Spray-Dried Amorphous Solid Dispersions: Assessment of Thermodynamic Models, Standard Screening Methods and a Novel Atomization Screening Device with Regard to Prediction Accuracy.喷雾干燥无定形固体分散体相行为的预测:关于预测准确性对热力学模型、标准筛选方法及一种新型雾化筛选装置的评估
Pharmaceutics. 2018 Mar 7;10(1):29. doi: 10.3390/pharmaceutics10010029.
8
The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.重组无序的无定形药物制剂科学的必要性。
Pharm Res. 2017 Sep;34(9):1754-1772. doi: 10.1007/s11095-017-2174-7. Epub 2017 May 18.
9
Drug-Loadable Calcium Alginate Hydrogel System for Use in Oral Bone Tissue Repair.用于口腔骨组织修复的可载药海藻酸钙水凝胶系统
Int J Mol Sci. 2017 May 6;18(5):989. doi: 10.3390/ijms18050989.
10
In vitro comparison of three rifampicin loading methods in a reinforced porous β-tricalcium phosphate scaffold.强化多孔β-磷酸三钙支架中三种利福平负载方法的体外比较
J Mater Sci Mater Med. 2015 Apr;26(4):174. doi: 10.1007/s10856-015-5437-z. Epub 2015 Mar 28.

本文引用的文献

1
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors.B-Raf(V600E)的吡唑并吡啶抑制剂。第1部分:选择性、口服生物可利用且有效的抑制剂的研发。
ACS Med Chem Lett. 2011 Mar 8;2(5):342-7. doi: 10.1021/ml200025q. eCollection 2011 May 12.
2
Species comparison of oral bioavailability, first-pass metabolism and pharmacokinetics of acetaminophen.对乙酰氨基酚口服生物利用度、首过代谢和药代动力学的种属比较。
Res Vet Sci. 2010 Aug;89(1):113-9. doi: 10.1016/j.rvsc.2010.02.002. Epub 2010 Mar 7.
3
Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS.评价灰黄霉素二元和三元固体分散体与 HPMCAS 的效果。
AAPS PharmSciTech. 2009;10(4):1172-7. doi: 10.1208/s12249-009-9319-x. Epub 2009 Oct 20.
4
Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.含无定形固体分散体的聚乙烯吡咯烷酮在有水分存在下的相行为
Mol Pharm. 2009 Sep-Oct;6(5):1492-505. doi: 10.1021/mp900050c.
5
Anomalous properties of spray dried solid dispersions.喷雾干燥固体分散体的异常性质。
J Pharm Sci. 2009 Dec;98(12):4724-37. doi: 10.1002/jps.21782.
6
Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole.使用浓度增强聚合物提高伊曲康唑生物利用度的无定形组合物。
Mol Pharm. 2008 Nov-Dec;5(6):968-80. doi: 10.1021/mp800042d.
7
Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu.羟丙基甲基纤维素琥珀酸酯(HPMCAS)在胃肠道环境中引发和维持药物过饱和状态的效用。
Pharm Res. 2009 Jun;26(6):1419-31. doi: 10.1007/s11095-009-9852-z. Epub 2009 Mar 10.
8
Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview.基于羟丙基甲基纤维素醋酸琥珀酸酯的喷雾干燥分散体:综述
Mol Pharm. 2008 Nov-Dec;5(6):1003-19. doi: 10.1021/mp8000793.
9
Amorphous pharmaceutical solids: characterization, stabilization, and development of marketable formulations of poorly soluble drugs with improved oral absorption.无定形药物固体:难溶性药物具有改善口服吸收的可销售制剂的表征、稳定化及开发
Mol Pharm. 2008 Nov-Dec;5(6):903-4. doi: 10.1021/mp800203k.
10
Scaling up the spray drying process from pilot to production scale using an atomized droplet size criterion.使用雾化液滴尺寸标准将喷雾干燥工艺从试验规模扩大到生产规模。
Pharm Res. 2008 Jul;25(7):1610-20. doi: 10.1007/s11095-008-9565-8. Epub 2008 Apr 11.

采用 96 孔板真空干燥系统评价无定形固体分散体药物传递中的载药量和聚合物。

Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery.

机构信息

Global Research and Development, SMPS, Genentech Inc., 1 DNA Way, South San Francisco, California 4080, USA.

出版信息

AAPS PharmSciTech. 2012 Jun;13(2):713-22. doi: 10.1208/s12249-012-9795-2. Epub 2012 May 5.

DOI:10.1208/s12249-012-9795-2
PMID:22562615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3364400/
Abstract

It is well recognized that poor dissolution rate and solubility of drug candidates are key limiting factors for oral bioavailability. While numerous technologies have been developed to enhance solubility of the drug candidates, poor water solubility continuously remains a challenge for drug delivery. Among those technologies, amorphous solid dispersions (SD) have been successfully employed to enhance both dissolution rate and solubility of poorly water-soluble drugs. This research reports a high-throughput screening technology developed by utilizing a 96-well plate system to identify optimal drug load and polymer using a solvent casting approach. A minimal amount of drug was required to evaluate optimal drug load in three different polymers with respect to solubility improvement and solid-state stability of the amorphous drug-polymer system. Validation of this method was demonstrated with three marketed drugs as well as with one internal compound. Scale up of the internal compound SD by spray drying further confirmed the validity of this method, and its quality was comparable to a larger scale process. Here, we demonstrate that our system is highly efficient, cost-effective, and robust to evaluate the feasibility of spray drying technology to produce amorphous solid dispersions.

摘要

人们普遍认识到,药物候选物的溶解速率和溶解度差是口服生物利用度的关键限制因素。虽然已经开发出许多技术来提高候选药物的溶解度,但较差的水溶性仍然是药物输送的一个挑战。在这些技术中,无定形固体分散体(SD)已成功用于提高水溶性差的药物的溶解速率和溶解度。本研究报告了一种高通量筛选技术,该技术利用 96 孔板系统,通过溶剂浇铸法来确定最佳的药物载药量和聚合物。仅需少量药物即可评估三种不同聚合物中最佳的药物载药量,以提高药物的溶解度和无定形药物-聚合物体系的固体稳定性。该方法通过喷雾干燥对三种市售药物和一种内部化合物进行了验证,进一步证实了该方法的有效性,其质量与大规模工艺相当。在这里,我们证明了我们的系统是高效、经济高效且稳健的,可以评估喷雾干燥技术生产无定形固体分散体的可行性。